Quarter
Charts

Ultragenyx Pharmaceutical Inc.

RARE

CIK 0001515673 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$207M
↑+25.9% +$43Mvs FY2024 (Q4)
Gross Profit
$207M
↑+25.9% +$43Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
53/100
  • Profitability
    0ROIC -483.0% (10% = solid, 20%+ = moat)
  • Liquidity
    99Current Ratio 2.48 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    19Asset Turnover 0.44x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +25.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -106.9% · trend +17.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$6M
investment in PP&E
Dividends paid (TTM)
—
cash returned to holders
Stock-based comp (TTM)
—
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.53B
everything owned
Total liabilities
$1.60B
everything owed
Stockholders' equity
$-80M
shareholder claim

Recent performance · 53 quarters

Revenue↑+25.9% +$43M
$207M
Net Income↓-35.1% -$47M
$-180M
Free Cash Flow↓-475.5% -$775K
$-938K
Operating Margin↓-12.2pts
-106.9%

Drill down

RARE Sankey

See Ultragenyx Pharmaceutical Inc.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

RARE Charts

53 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

RARE Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics